{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:20:41Z","timestamp":1760833241188,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.nmd.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T23:27:16Z","timestamp":1633994836000},"page":"1282-1286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical trajectory of a patient with filaminopathy who developed arrhythmogenic cardiomyopathy, myofibrillar myopathy, and multiorgan tumors"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6241-3626","authenticated-orcid":false,"given":"Tsuyoshi","family":"Matsumura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1629-3947","authenticated-orcid":false,"given":"Keiko","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2757-3266","authenticated-orcid":false,"given":"Michio","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7538-1651","authenticated-orcid":false,"given":"Aritoshi","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3754-8593","authenticated-orcid":false,"given":"Tatsuya","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8890-2743","authenticated-orcid":false,"given":"Goichi","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harutoshi","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2021.10.002_bib0001","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1086\/431959","article-title":"A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy","volume":"77","author":"Vorgerd","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.10.002_bib0002","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ejhg.2008.226","article-title":"In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy","volume":"17","author":"Shatunov","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2021.10.002_bib0003","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/01.WNL.0000156524.95261.B9","article-title":"A new dominant distal myopathy affecting posterior leg and anterior upper limb muscles","volume":"64","author":"Williams","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.10.002_bib0004","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajhg.2011.04.021","article-title":"Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy","volume":"88","author":"Duff","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.10.002_bib0005","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1038\/ncomms6326","article-title":"Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy","volume":"5","author":"Vald\u00e9s-Mas","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.nmd.2021.10.002_bib0006","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/humu.22942","article-title":"Mutations in FLNC are associated with familial restrictive cardiomyopathy","volume":"37","author":"Brodehl","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.10.002_bib0007","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC Mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nmd.2021.10.002_bib0008","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.148.1.115","article-title":"Filamin 2 (FLN2): a muscle-specific sarcoglycan interacting protein","volume":"148","author":"Thompson","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2021.10.002_bib0009","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00401-012-1054-9","article-title":"Filamin C-related myopathies: pathology and mechanisms","volume":"125","author":"F\u00fcrst","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nmd.2021.10.002_bib0010","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4161\/cam.5.2.14401","article-title":"The filamins","volume":"5","author":"Nakamura","year":"2011","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.nmd.2021.10.002_bib0011","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2016.11.037","article-title":"Ectopic overexpression of filamin C scaffolds MEK1\/2 and ERK1\/2 to promote the progression of human hepatocellular carcinoma","volume":"388","author":"Yang","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nmd.2021.10.002_bib0012","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.18632\/oncotarget.2645","article-title":"Filamin C, a dysregulated protein in cancer revealed by label-free quantitative proteomic analyses of human gastric cancer cells","volume":"6","author":"Qiao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.nmd.2021.10.002_bib0013","doi-asserted-by":"crossref","first-page":"80655","DOI":"10.18632\/oncotarget.13019","article-title":"ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast","volume":"7","author":"Ping","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.nmd.2021.10.002_bib0014","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41416-019-0413-x","article-title":"High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme","volume":"120","author":"Kamil","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nmd.2021.10.002_bib0015","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/jamaneurol.2015.2274","article-title":"Use of whole-exome sequencing for diagnosis of limb-girdle muscular dystrophy: outcomes and lessons learned","volume":"72","author":"Ghaoui","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2021.10.002_bib0016","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/humu.24004","article-title":"A mutation update for the FLNC gene in myopathies and cardiomyopathies","volume":"41","author":"Verdonschot","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.10.002_bib0017","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/cge.13594","article-title":"FLNC pathogenic variants in patients with cardiomyopathies: prevalence and genotype-phenotype correlations","volume":"96","author":"Ader","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2021.10.002_bib0018","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/07357900802620794","article-title":"Hypermethylation of genes for diagnosis and risk stratification of prostate cancer","volume":"27","author":"Vanaja","year":"2009","journal-title":"Cancer Invest"},{"key":"10.1016\/j.nmd.2021.10.002_bib0019","doi-asserted-by":"crossref","unstructured":"Ai J., Jin T., Yang L., Wei Q., Yang Y., Li H., et al. Vinculin and filamin-C are two potential prognostic biomarkers and therapeutic targets for prostate cancer cell migration. 2017;8:82430\u20136. https:\/\/doi.org\/10.18632\/oncotarget.19397.","DOI":"10.18632\/oncotarget.19397"},{"key":"10.1016\/j.nmd.2021.10.002_bib0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.canlet.2005.10.010","article-title":"Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines","volume":"241","author":"Imura","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nmd.2021.10.002_bib0021","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3892\/or.2017.5433","article-title":"Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network","volume":"37","author":"Li","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.nmd.2021.10.002_bib0022","doi-asserted-by":"crossref","first-page":"R341","DOI":"10.1530\/ERC-13-0364","article-title":"The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it","volume":"20","author":"Savoy","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.nmd.2021.10.002_bib0023","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12253-015-9980-1","article-title":"Filamin A: insights into its exact role in cancers","volume":"22","author":"Shao","year":"2016","journal-title":"Pathol Oncol Res"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621006714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621006714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:12:04Z","timestamp":1760775124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621006714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0960896621006714"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.10.002","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical trajectory of a patient with filaminopathy who developed arrhythmogenic cardiomyopathy, myofibrillar myopathy, and multiorgan tumors","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}